{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:07Z","timestamp":1791644287529,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/35\/2020\/BIO\/BMS"],"award-info":[{"award-number":["45\/35\/2020\/BIO\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SERB, DST","award":["TARE\/2019\/000110"],"award-info":[{"award-number":["TARE\/2019\/000110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05323-8","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:44:30Z","timestamp":1778035470000},"page":"16079-16102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The design and synthesis of cysteine protease inhibitors containing isoxazole bearing warheads against Leishmania donovani"],"prefix":"10.1007","volume":"399","author":[{"given":"Gowsia","family":"Akhter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza A.","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeed ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angamuthu","family":"Selvapandiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalicharan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Sarfaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sarwar","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq A.","family":"Tantray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinna","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"5323_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"issue":"1","key":"5323_CR2","first-page":"21","volume":"5","author":"B Ado","year":"2025","unstructured":"Ado B, Usman U, Kir IZ, Sani HA, Babandi B, Gumel IA (2025) Advances in vector-borne protozoan diseases and control: challenges, innovations, and future directions\u2013a review. East J Agric Biol Sci 5(1):21\u201339","journal-title":"East J Agric Biol Sci"},{"issue":"31","key":"5323_CR3","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.2174\/0109298673310232240910062647","volume":"32","author":"G Akhter","year":"2025","unstructured":"Akhter G, Hamid H, Beg MA, Tantray MA, Dhawan B, Alam MS, Selvapandiyan A, Rehman SU, Kalicharan S (2025) Design and synthesis of benzimidazole carboxamide cysteine protease inhibitors as promising anti-leishmanial agents. Curr Med Chem 32(31):6900\u20136928","journal-title":"Curr Med Chem"},{"issue":"4","key":"5323_CR4","first-page":"159","volume":"12","author":"KM Al Azzam","year":"2022","unstructured":"Al Azzam KM, Negim E-S, Aboul-Enein HY (2022) ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: in silico study. J Appl Pharm Sci 12(4):159\u2013169","journal-title":"J Appl Pharm Sci"},{"issue":"3","key":"5323_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/infdis\/jiae579","volume":"231","author":"F Almeida-Val","year":"2025","unstructured":"Almeida-Val F, Goulart CdaL, Monteiro WM, Tinoco Areas GP (2025) When surviving neglected tropical diseases is not enough. J Infect Dis 231(3):822\u2013823","journal-title":"J Infect Dis"},{"key":"5323_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131604","volume":"1249","author":"L Alonso","year":"2022","unstructured":"Alonso L, Pianoski KE, Alonso A, Rosa FA (2022) Antileishmanial activity of 3,4,5-trisubstituted isoxazoles by interaction with Leishmania amazonensis plasma membrane. J Mol Struct 1249:131604","journal-title":"J Mol Struct"},{"issue":"2","key":"5323_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.31643\/2023\/6445.13","volume":"325","author":"KAL Azzam","year":"2023","unstructured":"Azzam KAL (2023) SwissADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME\/T properties of artemisinin and its derivatives. Kompl Ispolz Min Syra= Compl Use Min Resour 325(2):14\u201321","journal-title":"Kompl Ispolz Min Syra= Compl Use Min Resour"},{"issue":"8","key":"5323_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081913","volume":"10","author":"O Barreiro-Costa","year":"2022","unstructured":"Barreiro-Costa O, Quiroga Lozano C, Mu\u00f1oz E, Rojas-Silva P, Medeiros A, Comini MA, Heredia-Moya J (2022) Evaluation of the anti-Leishmania mexicana and-Trypanosoma brucei activity and mode of action of 4, 4\u2032-(arylmethylene) bis (3-methyl-1-phenyl-1 H-pyrazol-5-ol). Biomedicines 10(8):1913","journal-title":"Biomedicines"},{"issue":"2","key":"5323_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar P, Larsson P, Cuendet MA, Hess B, Lindahl E (2010) Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput 6(2):459\u2013466","journal-title":"J Chem Theory Comput"},{"key":"5323_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/B978-012473346-6\/50012-0","volume-title":"Molecular and medical parasitology","author":"NS Carter","year":"2003","unstructured":"Carter NS (2003) Molecular and medical parasitology. Ac. Press, UK, pp 197\u2013223"},{"key":"5323_CR11","first-page":"380","volume":"54","author":"A Cho","year":"2022","unstructured":"Cho A, Lee N, Phan TN, Kim S, Lee H, Lee H, Shum D, No JH (2022) High-throughput drug screening using leishmania amastigotes and promastigotes for potential therapeutics against leishmaniasis. Infect Chemother 54:380\u2013380","journal-title":"Infect Chemother"},{"issue":"12","key":"5323_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11122845","volume":"11","author":"HN Corman","year":"2023","unstructured":"Corman HN, McNamara CW, Bakowski MA (2023) Drug discovery for cutaneous leishmaniasis: a review of developments in the past 15 years. Microorganisms 11(12):2845","journal-title":"Microorganisms"},{"issue":"11","key":"5323_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","volume":"21","author":"SL Croft","year":"2005","unstructured":"Croft SL, Barrett MP, Urbina JA (2005) Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 21(11):508\u2013512","journal-title":"Trends Parasitol"},{"key":"5323_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejmech.2017.01.029","volume":"128","author":"R da Rosa","year":"2017","unstructured":"da Rosa R, de Moraes MH, Zimmermann LA, Schenkel EP, Steindel M, Bernardes LSC (2017) Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis. Eur J Med Chem 128:25\u201335. https:\/\/doi.org\/10.1016\/j.ejmech.2017.01.029","journal-title":"Eur J Med Chem"},{"issue":"11","key":"5323_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V (2016) A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11(11):1117\u20131121","journal-title":"ChemMedChem"},{"issue":"5","key":"5323_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/acsinfecdis.3c00090","volume":"9","author":"AR das Neves","year":"2023","unstructured":"das Neves AR, Carvalho DB, Silva F, Rosalem RF, Pelizaro BI, Castilho PF, Oliveira KMP, Cassemiro NS, Pessatto LR, Paredes-Gamero EJ, Piranda EM, Silva DB, Arruda CCP, Baroni ACM (2023) In vivo antileishmanial effect of 3,5-diaryl-isoxazole analogues based on veraguensin, grandisin, and machilin G: a glance at a preclinical study. ACS Infect Dis 9(5):1150\u20131159. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00090","journal-title":"ACS Infect Dis"},{"issue":"14","key":"5323_CR17","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2174\/1389557523666230127125058","volume":"23","author":"KM de Santiago-Silva","year":"2023","unstructured":"de Santiago-Silva KM, da Silva Gomes GF, Perez CC, da Silva Lima CH, de Lima Ferreira Bispo M (2023) Molecular targets for chalcones in antileishmanial drug discovery. Mini Rev Med Chem 23(14):1414\u20131434","journal-title":"Mini Rev Med Chem"},{"key":"5323_CR18","doi-asserted-by":"crossref","unstructured":"Dhingra N, Kapoor K, Sharma S, Ameta KL (2022) Exploring the structural insights of trisubstituted isoxazoles against protozoal agents using QSAR and molecular docking model","DOI":"10.21203\/rs.3.rs-1716908\/v1"},{"issue":"4","key":"5323_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/1871526518666180502141849","volume":"19","author":"AAAB Dukhyil","year":"2019","unstructured":"Dukhyil AAAB (2019) Targeting trypanothione reductase of Leishmanial major to fight against cutaneous leishmaniasis. Infect Disord Drug Targets 19(4):388\u2013393","journal-title":"Infect Disord Drug Targets"},{"issue":"2","key":"5323_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020776","volume":"28","author":"J Dulsat","year":"2023","unstructured":"Dulsat J, L\u00f3pez-Nieto B, Estrada-Tejedor R, Borrell JI (2023) Evaluation of free online ADMET tools for academic or small biotech environments. Molecules 28(2):776","journal-title":"Molecules"},{"issue":"4","key":"5323_CR21","doi-asserted-by":"publisher","first-page":"23608","DOI":"10.34117\/bjdv8n4-059","volume":"8","author":"AS Figueredo","year":"2022","unstructured":"Figueredo AS, Assen\u00e7o JNF, da Costa AAC, da Silva L\u00f3pez RE, da Silva MCP (2022) Protease inhibitor activity of plant natural products as leishmanicine agents Atividade de inibidores de proteases de produtos naturais contra agentes leishmanicidas. Braz J Dev 8(4):23608\u201323632","journal-title":"Braz J Dev"},{"key":"5323_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2022.108253","volume":"236","author":"ALA Gouveia","year":"2022","unstructured":"Gouveia ALA, Santos FAB, Alves LC, Cruz-Filho IJ, Silva PR, Jacob ITT, Soares JCS, Santos DKDN, Souza TRCL, Oliveira JF (2022) Thiazolidine derivatives: in vitro toxicity assessment against promastigote and amastigote forms of Leishmania infantum and ultrastructural study. Exp Parasitol 236:108253","journal-title":"Exp Parasitol"},{"key":"5323_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113606","volume":"223","author":"O Gupta","year":"2021","unstructured":"Gupta O, Pradhan T, Bhatia R, Monga V (2021) Recent advancements in anti-leishmanial research: synthetic strategies and structural activity relationships. Eur J Med Chem 223:113606","journal-title":"Eur J Med Chem"},{"issue":"4","key":"5323_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1039\/c3md00282a","volume":"5","author":"R Haavikko","year":"2014","unstructured":"Haavikko R, Nasereddin A, Sacerdoti-Sierra N, Kopelyanskiy D, Alakurtti S, Tikka M, Jaffe CL, Yli-Kauhaluoma J (2014) Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes. Med Chem Commun 5(4):445\u2013451. https:\/\/doi.org\/10.1039\/c3md00282a","journal-title":"Med Chem Commun"},{"key":"5323_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2021.e00201","volume":"12","author":"M Ilaghi","year":"2021","unstructured":"Ilaghi M, Sharifi I, Sharififar F, Sharifi F, Oliaee RT, Babaei Z, Meimamandi MS, Keyhani A, Bamorovat M (2021) The potential role and apoptotic profile of three medicinal plant extracts on Leishmania tropica by MTT assay, macrophage model and flow cytometry analysis. Parasite Epidemiology and Control 12:e00201. https:\/\/doi.org\/10.1016\/j.parepi.2021.e00201","journal-title":"Parasite Epidemiology and Control"},{"key":"5323_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116365","volume":"46","author":"WAS Judice","year":"2021","unstructured":"Judice WAS, Ferraz LS, de Mello Lopes R, dos Santos Vianna L, da Silva Siqueira F, Di Iorio JF, Dalzoto LM, Trujilho MNR, dos Reis Santos T, Machado MFM (2021) Cysteine proteases as potential targets for anti-trypanosomatid drug discovery. Bioorg Med Chem 46:116365","journal-title":"Bioorg Med Chem"},{"key":"5323_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105457","volume":"166","author":"PK Kushawaha","year":"2022","unstructured":"Kushawaha PK, Tripathi CDP, Dube A (2022) Leishmania donovani secretory protein nucleoside diphosphate kinase b localizes in its nucleus and prevents ATP mediated cytolysis of macrophages. Microb Pathog 166:105457","journal-title":"Microb Pathog"},{"issue":"9","key":"5323_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009742","volume":"15","author":"S Malvolti","year":"2021","unstructured":"Malvolti S, Malhame M, Mantel CF, Le Rutte EA, Kaye PM (2021) Human leishmaniasis vaccines: use cases, target population and potential global demand. PLoS Negl Trop Dis 15(9):e0009742","journal-title":"PLoS Negl Trop Dis"},{"key":"5323_CR29","doi-asserted-by":"crossref","unstructured":"Mishra SK, Georrge JJ (2025) A recent update on visceral leishmaniasis and post-kala-azar dermal leishmaniasis: epidemiology, diagnosis, and treatments. In: Visceral leishmaniasis and post-kala-azar dermal leishmaniasis. CRC Press, pp 138\u2013158","DOI":"10.1201\/9781032643120-11"},{"issue":"5","key":"5323_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052025","volume":"26","author":"PQ Monteiro","year":"2025","unstructured":"Monteiro PQ, Schaeffer E, da Silva AJM, Alves CR, Souza-Silva F (2025) A virtual screening approach to evaluate the multitarget potential of a chalcone library with binding properties to oligopeptidase B and cysteine proteinase B from Leishmania (Viannia) braziliensis. Int J Mol Sci 26(5):2025","journal-title":"Int J Mol Sci"},{"issue":"9496","key":"5323_CR31","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366(9496):1561\u20131577","journal-title":"Lancet"},{"key":"5323_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exppara.2017.11.009","volume":"184","author":"R Nieto-Meneses","year":"2018","unstructured":"Nieto-Meneses R, Castillo R, Hern\u00e1ndez-Campos A, Maldonado-Rangel A, Matius-Ruiz JB, Trejo-Soto PJ, Nogueda-Torres B, Dea-Ayuela MA, Bol\u00e1s-Fern\u00e1ndez F, M\u00e9ndez-Cuesta C (2018) In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Exp Parasitol 184:82\u201389","journal-title":"Exp Parasitol"},{"issue":"1","key":"5323_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cmdc.201500496","volume":"11","author":"A Pinto","year":"2016","unstructured":"Pinto A, Tamborini L, Cullia G, Conti P, De Micheli C (2016) Inspired by nature: the 3-halo-4,5-dihydroisoxazole moiety as a novel molecular warhead for the design of covalent inhibitors. ChemMedChem 11(1):10\u201314. https:\/\/doi.org\/10.1002\/cmdc.201500496","journal-title":"ChemMedChem"},{"issue":"1","key":"5323_CR34","doi-asserted-by":"publisher","first-page":"12021","DOI":"10.1088\/1755-1315\/890\/1\/012021","volume":"890","author":"PH Riyadi","year":"2021","unstructured":"Riyadi PH, Sari ID, Kurniasih RA, Agustini TW, Swastawati F, Herawati VE, Tanod WA (2021) SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in spirulina platensis. IOP Conf Ser Earth Environ Sci 890(1):12021","journal-title":"IOP Conf Ser Earth Environ Sci"},{"issue":"2","key":"5323_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0113894501324437240919064715","volume":"26","author":"AL Rodriguez Gini","year":"2025","unstructured":"Rodriguez Gini AL, Jo\u00e3o EE, Lopes JR, Da Cunha PST, Arenas Vel\u00e1squez AM, Graminha MAS, dos Santos JL, Scarim CB (2025) Advances in cysteine protease B inhibitors for leishmaniasis treatment. Curr Drug Targets 26(2):88\u2013108","journal-title":"Curr Drug Targets"},{"issue":"10","key":"5323_CR36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/open.202100141","volume":"10","author":"FA Rosa","year":"2021","unstructured":"Rosa FA, Mendes de Souza Melo S, Pianoski KE, Poletto J, Dos Santos MG, Vieira da Silva MJ, Lazarin\u2010Bid\u00f3ia D, Volpato H, Moura S, Nakamura CV (2021) Synthesis and antiprotozoal profile of 3, 4, 5\u2010trisubstituted isoxazoles. ChemistryOpen 10(10):931\u2013938","journal-title":"ChemistryOpen"},{"key":"5323_CR37","doi-asserted-by":"crossref","unstructured":"Rout M, Nisad F, Das JK, Mohapatra SR, Hota A, Sahoo PK (2025) Pathology and emerging treatment of leishmaniasis: the India scenario","DOI":"10.20944\/preprints202503.0878.v1"},{"issue":"1","key":"5323_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11030-024-10876-y","volume":"29","author":"S Saha","year":"2025","unstructured":"Saha S, Sharma A, Bhowmik D, Kumar D (2025) Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study. Mol Divers 29(1):575\u2013590","journal-title":"Mol Divers"},{"key":"5323_CR39","doi-asserted-by":"crossref","unstructured":"Selvapandiyan A, Croft SL, Rijal S, Nakhasi HL, Ganguly NK (2019) Innovations for the elimination and control of visceral leishmaniasis. In: PLoS neglected tropical diseases, Vol. 13, Issue 9. Public Library of Science, San Francisco, p e0007616","DOI":"10.1371\/journal.pntd.0007616"},{"issue":"1","key":"5323_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuac041","volume":"47","author":"A Selvapandiyan","year":"2023","unstructured":"Selvapandiyan A, Puri N, Kumar P, Alam A, Ehtesham NZ, Griffin G, Hasnain SE (2023) Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: potential broad-spectrum therapeutic targets against infectious diseases. FEMS Microbiol Rev 47(1):fuac041","journal-title":"FEMS Microbiol Rev"},{"issue":"29","key":"5323_CR41","volume":"8","author":"S Sharma","year":"2023","unstructured":"Sharma S, Anjaneyulu Yakkala P, Beg MA, Tanwar S, Latief I, Khan A, Sharma K, ur Rehman S, Selvapandiyan A, Shafi S (2023) 5\u2010arylidene\u20102, 4\u2010thiazolidinediones as cysteine protease inhibitors against Leishmania donovani. ChemSelect 8(29):e202302415","journal-title":"ChemSelect"},{"key":"5323_CR42","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202320230566","volume":"95","author":"BRMGDA Silva","year":"2023","unstructured":"Silva BRMGDA, J\u00fanior B, Da Silva N, Oliveira JF, Duarte D, Maria FA, Marques DSC, Nogueira F, Lima MCA, Cruz Filho IJDA (2023) In silico ADMET prediction, evaluation of cytotoxicity in mouse splenocytes and preliminary evaluation of in vitro antimalarial activity of 4-(4-chlorophenyl) thiazole compounds. An Acad Bras Cienc 95:e20230566","journal-title":"An Acad Bras Cienc"},{"issue":"1","key":"5323_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45436-1","volume":"13","author":"AC Silva de Jesus Passaes","year":"2023","unstructured":"Silva de Jesus Passaes AC, Arantes Dantas J, Landim Lopes F, Pereira Sangi D, Gir\u00e3o Albuquerque M, Vataru Nakamura C, Yoneda J (2023) Quinoxalines against Leishmania amazonensis: SAR study, proposition of a new derivative, QSAR prediction, synthesis, and biological evaluation. Sci Rep 13(1):18136","journal-title":"Sci Rep"},{"key":"5323_CR44","doi-asserted-by":"crossref","unstructured":"Singh K, Bhavani R, Sharma S (2025) 5 A drug current discovery scenario against of visceral leishmaniasis. Visceral leishmaniasis and post-kala-azar dermal leishmaniasis: pathogenesis, treatment and disease control. 47","DOI":"10.1201\/9781032643120-5"},{"issue":"8","key":"5323_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11080950","volume":"11","author":"M Soni","year":"2022","unstructured":"Soni M, Pratap JV (2022) Development of novel anti-leishmanials: the case for structure-based approaches. Pathogens 11(8):950","journal-title":"Pathogens"},{"key":"5323_CR46","doi-asserted-by":"crossref","unstructured":"Sundar S, Madhukar P, Kumar R (2025) Anti-leishmanial therapies: overcoming current challenges with emerging therapies. Expert Review of Anti-Infective Therapy, just-accepted","DOI":"10.1080\/14787210.2024.2438627"},{"key":"5323_CR47","doi-asserted-by":"publisher","unstructured":"Suryawanshi SN, Tiwari A, Chandra N, Ramesh, Gupta S (2012) Chemotherapy of leishmaniasis. Part XI: synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives. Bioorg Med Chem Lett 22(21):6559\u20136562. https:\/\/doi.org\/10.1016\/j.bmcl.2012.09.024","DOI":"10.1016\/j.bmcl.2012.09.024"},{"key":"5323_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201900241","volume":"353","author":"OS Trefzger","year":"2020","unstructured":"Trefzger OS, Barbosa NV, Scapolatempo RL, Das Neves AR, Ortale MLFS, Carvalho DB, Honorato AM, Fragoso MR, Shuiguemoto CYK, Perdomo RT, Matos MFC, Chang MR, Arruda CCP, Baroni ACM (2020) Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds. Arch Pharm 353:e1900241","journal-title":"Arch Pharm"},{"key":"5323_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/cbdd.13417","volume":"93","author":"OS Trefzger","year":"2019","unstructured":"Trefzger OS, Das Neves AR, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, De Albuquerque S, Arruda CCP, Baroni ACM (2019) Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans Veraguensin, Grandisin and Machilin G. Chem Biol Drug Des 93:313","journal-title":"Chem Biol Drug Des"},{"key":"5323_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22030997","author":"L Tu\u0161ar","year":"2021","unstructured":"Tu\u0161ar L, Usenik A, Turk B, Turk D (2021) Mechanisms applied by protein inhibitors to inhibit cysteine proteases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22030997","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5323_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-020-00267-2","volume":"15","author":"MS Vald\u00e9s-Tresanco","year":"2020","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2020) AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4. Biol Direct 15(1):1\u201312","journal-title":"Biol Direct"},{"key":"5323_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07178","author":"PM Wadanambi","year":"2021","unstructured":"Wadanambi PM, Mannapperuma U (2021) Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from Leishmania donovani. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07178","journal-title":"Heliyon"},{"issue":"1","key":"5323_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang H, Yan R, Liu Y, Yu M, He Z, Xiao J, Li K, Liu G, Ning Q, Li Y (2025) Progress in antileishmanial drugs: mechanisms, challenges, and prospects. PLoS Negl Trop Dis 19(1):e0012735","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"5323_CR54","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32(11):2359\u20132368","journal-title":"J Comput Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05323-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:47Z","timestamp":1784775827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05323-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5323"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05323-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}